Nautilus Biotechnology Files Q1 2025 10-Q
Ticker: NAUT · Form: 10-Q · Filed: Apr 29, 2025 · CIK: 1808805
| Field | Detail |
|---|---|
| Company | Nautilus Biotechnology, INC. (NAUT) |
| Form Type | 10-Q |
| Filed Date | Apr 29, 2025 |
| Risk Level | medium |
| Sentiment | neutral |
Sentiment: neutral
Topics: 10-Q, financials, biotechnology, reporting
Related Tickers: ARIA
TL;DR
Nautilus Bio (NAUT) filed its Q1 2025 10-Q, showing financial updates. No major surprises yet.
AI Summary
Nautilus Biotechnology, Inc. filed its quarterly report for the period ending March 31, 2025. The company, formerly known as ARYA Sciences Acquisition Corp III, is focused on laboratory analytical instruments. The filing details financial data for the first quarter of 2025, including changes in common stock and additional paid-in capital.
Why It Matters
This filing provides investors with an update on Nautilus Biotechnology's financial position and operational activities for the first quarter of 2025, crucial for assessing the company's performance and future prospects.
Risk Assessment
Risk Level: medium — As a biotechnology company, Nautilus faces inherent risks related to research and development, regulatory approvals, and market adoption of its technologies.
Key Numbers
- 2025-03-31 — Reporting Period End Date (Indicates the end of the fiscal quarter being reported.)
- 2025-04-29 — Filing Date (Shows when the report was officially submitted to the SEC.)
Key Players & Entities
- Nautilus Biotechnology, Inc. (company) — Filer of the 10-Q report
- ARYA Sciences Acquisition Corp III (company) — Former name of Nautilus Biotechnology, Inc.
- 20250331 (date) — Conformed period of report
- 20250429 (date) — Filing date
FAQ
What is the primary business of Nautilus Biotechnology, Inc.?
Nautilus Biotechnology, Inc. is primarily involved in the business of laboratory analytical instruments, as indicated by its SIC code 3826.
What was the previous name of Nautilus Biotechnology, Inc.?
Nautilus Biotechnology, Inc. was formerly known as ARYA Sciences Acquisition Corp III, with a date of name change on April 8, 2020.
For what period is this 10-Q report filed?
This 10-Q report is filed for the period ended March 31, 2025.
When was this 10-Q report filed with the SEC?
This 10-Q report was filed on April 29, 2025.
What are the key financial statement components mentioned for the period?
The filing mentions components such as Common Stock, Additional Paid-In Capital, Accumulated Other Comprehensive Income, and Retained Earnings for the periods ending March 31, 2025, and December 31, 2024.
Filing Details
This Form 10-Q (Form 10-Q) was filed with the SEC on April 29, 2025 regarding Nautilus Biotechnology, Inc. (NAUT).